NCT02431065

Brief Summary

Rectus sheath block is effective in reducing pain in the peri-umbilical region, and the use of ultrasonography is recommended to perform the block at the precise location. Recently, intra-operative rectus sheath block has also been introduced without the aid of ultrasonography. However, no study has not yet compared the analgesic effects of these two different approaches (ultrasonography-guided vs direct surgical). Thus, the aim of our study is to compare the effect of ultrasonography-guided and direct-surgical rectus sheath block after single-port access laparoscopy in benign ovary cyst patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for phase_2 pain

Timeline
Completed

Started May 2015

Typical duration for phase_2 pain

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2015

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 30, 2015

Completed
1 day until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

May 4, 2015

Status Verified

April 1, 2015

Enrollment Period

1 year

First QC Date

April 17, 2015

Last Update Submit

April 30, 2015

Conditions

Keywords

Rectus sheath blockSingle port laparoscopy

Outcome Measures

Primary Outcomes (1)

  • The intensity of pain as assessed by Dose of fentanyl(opioid)

    Dose of fentanyl(opioid) self-administered by the patients within 24 hours of surgery

    within 24 hours of surgery

Secondary Outcomes (1)

  • Incident rate of side effects of fentanyl

    within 24 hours of surgery

Study Arms (3)

Group 3, Direct injection group

EXPERIMENTAL

Test group 2, Rectus sheath block will be performed under direct visualization. Ropivacaine (0.75%, 10ml) will be directly injected into the right and left rectus sheath at the end of the operation.

Procedure: Rectus sheath blockDrug: Ropivacaine

Group 2, ultrasonography group

ACTIVE COMPARATOR

Test group 1, Rectus sheath block will be performed under sonographic guidance. Ropivacaine (0.75%, 10ml) will be injected into the right and left rectus sheath under ultrasonographic guidance at the end of the operation.

Procedure: Rectus sheath blockDrug: Ropivacaine

Group 1

PLACEBO COMPARATOR

Control group, Rectus sheath block will be performed under sonographic guidance. Normal saline 10 ml will be injected into the right, left rectus sheath under ultrasonography guidance at the end of the operation.

Procedure: Rectus sheath blockOther: Normal saline

Interventions

Local anesthetics (Ropivacaine 0.75% 10ml) or normal saline (10ml) will be injected in the rectus sheath via different methods: 1. Control group Normal saline 10mL will be injected under ultrasonography guidance into the right, left rectus sheath at the end of the operation before emergence from general anesthesia. 2. Ultrasonography group Local anesthetic (Ropivacaine 0.75% 10 mL) will be injected under ultrasonography guidance into the right left rectus sheath at the end of the operation before emergence from general anesthesia. 3. Direct injection group Local anesthetic (Ropivacaine 0.75% 10 mL) will be injected under direct visualization into the right, left rectus sheath at the end of the operation before emergence from general anesthesia.

Also known as: anesthesia
Group 1Group 2, ultrasonography groupGroup 3, Direct injection group

Local anesthetics (Ropivacaine 0.75% 10ml) or normal saline (10ml) will be injected in the rectus sheath via different methods: 1. Control group Normal saline 10mL will be injected under ultrasonography guidance into the right, left rectus sheath at the end of the operation before emergence from general anesthesia. 2. Ultrasonography group Local anesthetic (Ropivacaine 0.75% 10 mL) will be injected under ultrasonography guidance into the right left rectus sheath at the end of the operation before emergence from general anesthesia. 3. Direct injection group Local anesthetic (Ropivacaine 0.75% 10 mL) will be injected under direct visualization into the right, left rectus sheath at the end of the operation before emergence from general anesthesia.

Also known as: surgery
Group 2, ultrasonography groupGroup 3, Direct injection group

Local anesthetics (Ropivacaine 0.75% 10ml) or normal saline (10ml) will be injected in the rectus sheath via different methods: 1. Control group Normal saline 10mL will be injected under ultrasonography guidance into the right, left rectus sheath at the end of the operation before emergence from general anesthesia. 2. Ultrasonography group Local anesthetic (Ropivacaine 0.75% 10 mL) will be injected under ultrasonography guidance into the right left rectus sheath at the end of the operation before emergence from general anesthesia. 3. Direct injection group Local anesthetic (Ropivacaine 0.75% 10 mL) will be injected under direct visualization into the right, left rectus sheath at the end of the operation before emergence from general anesthesia.

Also known as: No intervention
Group 1

Eligibility Criteria

Age20 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for a single port laparoscopic surgery at Chung Nam University hospital due to benign tumor of the ovary or the fallopian tube
  • Between age of twenty to seventy
  • Patients with a physical rating of 1 or 2 according to the American Anesthesiology guidelines
  • Patients who have not had laparoscopic surgery within two months

You may not qualify if:

  • Hysterectomy via single port laparoscopic surgery
  • Patients with chronic pelvic pain
  • Abdominal pain of unknown origin
  • Suspected malignant tumor
  • Diagnosed with malignant tumor of any origin
  • Patients currently taking psychiatric medicine
  • Pregnancy
  • Patients with a history of hypersensitivity to amide type local anesthetics
  • Patients with a history of hypersensitivity to opioid
  • Risk of bleeding
  • Unable to comprehend or does not agree to the consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Crosbie EJ, Massiah NS, Achiampong JY, Dolling S, Slade RJ. The surgical rectus sheath block for post-operative analgesia: a modern approach to an established technique. Eur J Obstet Gynecol Reprod Biol. 2012 Feb;160(2):196-200. doi: 10.1016/j.ejogrb.2011.10.015. Epub 2011 Nov 21.

    PMID: 22104479BACKGROUND
  • Osaka Y, Kashiwagi M, Nagatsuka Y, Oosaku M, Hirose C. [Ultrasound-guided rectus sheath block for upper abdominal surgery]. Masui. 2010 Aug;59(8):1039-41. Japanese.

    PMID: 20715537BACKGROUND

MeSH Terms

Conditions

Pain

Interventions

AnesthesiaRopivacaineSurgical Procedures, OperativeSaline Solution

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia and AnalgesiaAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Heon Jong Yoo, MD. PhD

    Chung Nam National University Hospital, clinical vice professor

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Vice professor

Study Record Dates

First Submitted

April 17, 2015

First Posted

April 30, 2015

Study Start

May 1, 2015

Primary Completion

May 1, 2016

Study Completion

May 1, 2017

Last Updated

May 4, 2015

Record last verified: 2015-04